HPV Vaccine Uptake Barriers – National Vaccination Campaign 2025 in Pakistan
DOI:
https://doi.org/10.57125/FEM.2026.09.30.01Abstract
Aims: In low- and lower-middle-income countries (LLMICs), the world's HPV-attributable mortality is highest. Human papillomavirus (HPV)-related malignancies, especially cervical cancer, continue to be a significant public health concern. Vaccination coverage is still poor in LLMICs, even after safe and effective vaccinations have been available for almost 20 years. Efforts to expand immunization programs in these contexts have been hampered by a number of obstacles, including systemic delivery issues and health misinformation.
Methodology: This study was an observational/cross-sectional comparative study to find the factors that motivated or blocked the uptake of the HPV vaccine at Lady Willingdon Hospital (LWH) during the national campaign in Pakistan during September 2025.
A questionnaire was administered to the girls and their parents coming to the vaccination center for vaccination, and mothers who were not willing to get the vaccination for their daughters. These mothers were selected from the patients coming into the OPD of LWH for their obstetrical or gynecological issues, and the study was completed from 15th September 2025 to 31st October 2025.
Results: Results show that vaccine uptake was higher in girls whose parents’ education was higher than that of the other group. In the group that did not get vaccination 56% girls were enrolled in school, whereas in the group that got vaccinated, 60% girls were enrolled in school at that time, so it was not statistically significant. Knowledge and awareness were poor in the non-vaccinated group and statistically significant. The strongest factor was social media misinformation, which acted as a barrier. At the same time, the strongest motivational factor was knowledge about the usefulness of the vaccine, which was acquired from doctors. The barrier, which was not included in the closed-ended question and came up from the open-ended question, was the misconception that this vaccine will decrease the reproductive capability of the girls, and it is the way adopted by the government to decrease population growth.
Scientific Novelty: It’s a policy-related, timely study that focuses on the behavior of society in response to a real campaign initiative by the government in Pakistan.
Conclusion: Coordinated, multi-level interventions that concurrently address behavioral and structural variables are necessary to increase HPV vaccine coverage in LLMICs. The results show that in order to guarantee successful implementation, community involvement, adaptable delivery methods, and long-term sustainability planning are essential. These findings directly affect national immunization policies, the development of the health system, and the accomplishment of international goals for the eradication of cervical cancer in settings with low resources. To advance equity in HPV-related cancer prevention, implementation must be tailored to the contextual realities of LLMICs.
References
Centers for Disease Control and Prevention. HPV vaccine safety and effectiveness [Internet]. Atlanta (GA): CDC; [cited 2026 Jul 10]. Available from: https://www.cdc.gov/vaccines/vpd/hpv/hcp/safety-effectiveness.html
National Cancer Institute. Human papillomavirus (HPV) vaccines [Internet]. Bethesda (MD): National Cancer Institute; 2024 [cited 2026 Jul 10]. Available from: https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet
Shamsi U, Anwar A, Samad Z. Time for reintroducing HPV vaccine in Pakistan for primary prevention of cervical cancer. J Pak Med Assoc. 2022;72(7):1377.
Wong LP, Han L, Li H, Zhao J, Zhao Q, Zimet GD. Current issues facing the introduction of the human papillomavirus vaccine in China and future prospects. Hum Vaccin Immunother. 2019;15(7-8):1533–1540. doi:10.1080/21645515.2019.1611157
Zaidi A, Kameleen F, Saleem MS, Raza AA, Samadi A. HPV vaccination and cervical cancer prevention in Pakistan: why are we so far behind? Ann Med Surg. 2026;88(6):3846.
Williamson AL. Recent developments in human papillomavirus (HPV) vaccinology. Viruses. 2023;15(7):1440. doi:10.3390/v15071440
Kyei GK, Kyei EF, Ansong R. HPV vaccine hesitancy and uptake: a conceptual analysis using Rodgers' evolutionary approach. J Adv Nurs. 2025;81(5):2368–2381. doi:10.1111/jan.16653
Sajid MI, Fatima F, Shahzadi HR, Sohaib SN, Ashfaq A. Cervical cancer control in Pakistan: a narrative policy review of HPV vaccination rollout and vaccine hesitancy. Pak Biomed J. 2026:13–20.
Zhou L, Li Y, Wang H, et al. Global cervical cancer elimination: quantifying the status, progress, and gaps. BMC Med. 2025;23:67. doi:10.1186/s12916-025-03897-3
Atif M. Human papillomavirus (HPV) and cervical cancer: a call to action for Pakistan. J Pak Med Assoc. 2025;75(8):1686–1687.
Dorji T, Nopsopon T, Tamang ST, Pongpirul K. Human papillomavirus vaccination uptake in low- and middle-income countries: a meta-analysis. EClinicalMedicine. 2021;34:100836. doi:10.1016/j.eclinm.2021.100836
Kisa S, Kisa A. Religious beliefs and practices toward HPV vaccine acceptance in Islamic countries: a scoping review. PLoS One. 2024;19(8):e0309597. doi:10.1371/journal.pone.0309597
Hamid MK, Hasneen S, Lima AK, Shawon SR, Shahriar M, Anjum R. Cervical cancer trends, HPV vaccine utilization, and screening in low- and lower-middle-income countries: an updated review. Ther Adv Vaccines Immunother. 2025;13:25151355251356646. doi:10.1177/25151355251356646
Khan MU, Ahmad A, Aqeel T, et al. Knowledge, attitudes and perceptions towards polio immunization among residents of two highly affected regions of Pakistan. BMC Public Health. 2015;15:1100. doi:10.1186/s12889-015-2471-1
Ali RF, Siddiqi DA, Mirza A, Naz N, Abdullah S, Kembhavi G, et al. Adolescent girls' recommendations for the design of a human papillomavirus vaccination program in Sindh, Pakistan: a qualitative study. Hum Vaccin Immunother. 2022;18(5):2045856. doi:10.1080/21645515.2022.2045856
Burney A, Zafar R. HPV vaccination as a mode of cervical cancer prevention in Pakistan. South Asian J Cancer. 2023;12(1):51–52.
Adegboyega A, Obielodan O, Wiggins AT, Dignan M, Williams LB. Beliefs and knowledge related to human papillomavirus (HPV) vaccine among African Americans and African immigrant young adults. Cancer Causes Control. 2023;34(5):479–489. doi:10.1007/s10552-023-01678-y
Halim SA, Patel T, Rizvi SV, Khabir M, Anand N. Overcoming barriers to HPV vaccination in Pakistan: a critical need for a proactive and culturally-sensitive strategy. Ann Med Surg. 2026;88(1):1048–1049.
Harrington N, Chen Y, O'Reilly AM, Fang CY. The role of trust in HPV vaccine uptake among racial and ethnic minorities in the United States: a narrative review. AIMS Public Health. 2021;8(2):352–368. doi:10.3934/publichealth.2021027
Abbasi FH, Shaikh AA, Mehraj J, et al. Vaccine hesitancy and perceptions of the community about polio in high-risk areas of Karachi, Sindh, Pakistan. Vaccines (Basel). 2023;11(1):70. doi:10.3390/vaccines11010070
Mehra R, Ray A, Kumari A, Kaur A, Hora R, Quadri SF, et al. Google trends for the human papillomavirus vaccine in India from 2010 to 2024: infodemiological study. J Med Internet Res. 2025;27:e69729. doi:10.2196/69729
Sharma M, Kaur I, Sandhu R, Kaur S. Human papillomavirus vaccine for cervical cancer prevention in India: new improvement and way forward. Int J Community Med Public Health. 2024;11(11):4554–4558.
Bhatla N, Meena J, Kumari S, Banerjee D, Singh P, Natarajan J. Cervical cancer prevention efforts in India. Indian J Gynecol Oncol. 2021;19(3):234.
Sundstrom B, Cartmell KB, White AA, Wells H, Pierce JY, Brandt HM. Correcting HPV vaccination misinformation online: evaluating the HPV Vaccination NOW social media campaign. Vaccines (Basel). 2021;9(4):352. doi:10.3390/vaccines9040352
Soofi SB, Vadsaria K, Mannan S, Habib MA, Tabassum F, Hussain I, et al. Factors associated with vaccine refusal (polio and routine immunization) in high-risk areas of Pakistan: a matched case-control study. Vaccines (Basel). 2023;11(5):947. doi:10.3390/vaccines11050947
World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: World Health Organization; 2020. p. 1–56.
Adedimeji A, Ajeh R, Pierz A, Nkeng R, Ndenkeh JJ, Fuhngwa N, et al. Challenges and opportunities associated with cervical cancer screening programs in a low income, high HIV prevalence context. BMC Womens Health. 2021;21(1):74. doi:10.1186/s12905-021-01211-w
Kumari P, Kumari S, Rani J, Abhilashi K, Sinha S, Pankaj S, et al. HPV vaccination program: hurdles and challenges in a tertiary care center! J Indira Gandhi Inst Med Sci. 2021;7(2):114.
Garg RK, Sharma B. Cervical cancer and human papilloma virus vaccination: gap and barriers. Int J Community Med Public Health. 2022;10(1):511–514.
Dwivedi P, Lahariya AU, Pandey S, Sreedevi A, Lohiya A, Lahariya C. Cervical cancer and human papilloma virus (HPV) vaccines: a primer for general physicians. Prev Med Res Rev. 2024;1(3):157–161.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 author

This work is licensed under a Creative Commons Attribution 4.0 International License.
